Substituted quinazolin-4-ones for inhibiting ubiquitin specific protease 7
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 17, 2017
Grant Date -
Dec 18, 2014
app pub date -
Aug 29, 2012
filing date -
Sep 2, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to quinazolin-4-one compounds of formula (I′), their process of preparation and uses thereof. These compounds are useful as selective and reversible inhibitors of ubiquitin specific proteases, particularly USP7, for treating e.g. cancer, neurodegenerative diseases, inflammatory disorders and viral infections.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully